Diabetes Devices And Drugs Market Size, 2017-2022 | Industry Report
The Latest Comprehensive
Industry research study titled, “Diabetes
Devices And Drugs Market by Products, Application - Global Industry
Analysis and Forecast To 2022” published by Crystal Market Research.
Diabetes occurs either when the pancreas does not produce
enough insulin or when the body cannot effectively use the insulin. Symptoms
associated with diabetes are frequent urination, blurred vision, increased
thirst, rapid weight loss, numbness or tingling sensation in hands or feet and
increased hunger. Factors which increase the risk of diabetes are ethnicity,
family history, unhealthy diet, physical inactivity and smoking. Diabetes can
damage the heart, eyes, blood vessels, kidneys, and nerves which may lead to
disability and premature death. There are three types of diabetes, namely, type
1, type 2 and gestational diabetes. Type 1 diabetes can cause due to complex
interaction between genes and environmental factors. The most common risk
factors for type 2 diabetes are overweight and obesity. However, gestational
diabetes develops only during pregnancy.
Continuous blood glucose monitoring devices continuously
monitors the blood sugar level and displays the data on the monitor. Flash
glucose monitors are also used to monitor blood glucose. The monitor shows
reading only after scanning its sensor. The insulin pump is a computerized
device that helps in controlling diabetes. This pump releases insulin through a
catheter into the body. The user can adjust the dose of insulin to be delivered
by this pump.
Anti diabetic drugs are used for controlling diabetes. These
medicines help to control and stabilize the blood glucose level. In patients
with type 1 diabetes, insulin is used, whereas in patients with type 2
diabetes, sulfonylurea, biguanides, meglitinides, dipeptidyl-peptidase-4
(DPP-4) inhibitors, alpha-glucosidase inhibitors, sodium glucose cotransporter
2 inhibitors (SGLT2), and glucagon-like peptide-1 (GLP-1) agonist are
used. In type 1 diabetes, the insulin used is created by growing insulin
proteins within E-coli bacteria in laboratory. The analog insulin is available
into various forms. One of the forms is long acting analog insulin. The long
acting analog insulin stays in the body for 24 hours, whereas the intermediate
acting analog insulin stays in the body for 16 to 24 hours. Another form of
insulin is rapid acting analog insulin. Rapid acting insulin stays the body for
3 to 5 hours. On the other hand, short acting analog stays in the body for 6 to
8 hours. Further, premixed analog insulin is also a form of insulin which is
used in diabetes. It is made by combining rapid acting and long acting insulin
in a ratio. However, in type 2 diabetes patients, sulfonylurea are used.
Sulfonylurea stimulate the insulin production in the pancreas. Moreover,
sulfonylurea help in increasing the
amount of insulin which is produced by the pancreas. Thiazolidinedione’s is
another class of anti diabetic drugs. Thiazolidinedione’s reduce insulin
resistance in fat and muscles. They also lower glucose production by the liver.
Meglitinide is another class of anti diabetic drug. Amount of insulin produced
by pancreas is increased with the help of meglitinides. Moreover, GLP-I
agonists help in maintenance of blood sugar in a target range without leading
to low blood sugar or weight gain, whereas alpha glucosidaseinhibitors slow
down the digestion of starch thus maintaining the blood sugar level.
Browse Complete Report:
https://www.crystalmarketresearch.com/report/diabetes-devices-and-drugs-market
The major driver for this market is increasing prevalence of diabetes. According
to International Diabetes Federation, in 2015, diabetes affected 415 million
people worldwide and this number is expected to reach up to 642 million by
2040. Thus, this rapidly rising diabetic population is set to drive the demand
for diabetes devices and drugs market. Additionally, increase in prevalence of
obesity in geriatric population is set to further drive the market growth. For
instance, as per WHO, in 2014, more than 1.9 billion adults, 18 years and
older, were overweight. Out of these, over 600 million were obese. Moreover, it
states that, in 2014, 41 million children whose age was under 5 were obese or
overweight. Further, increasing trend of unhealthy diet will contribute to the
growth of diabetes devices and drugs market. However, regulatory framework
issues will hamper the growth of diabetic devices and drug market.
The major strategy adopted by the major players is product
launch to gain market share and to gain competitive edge. For instance, in
2015, Janssen India launched INVOKANA for diabetic patients. INVOKANA is a
sodium glucose co-transporter 2 inhibitor. It helps adults to achieve adequate
control on diabetes who previously were not able to achieve control on
diabetes.
Major Market Players:
Ø
GlaxoSmithKline PLC
Ø
Abbott Laboratories
Ø
Takeda Pharmaceutical Company Limited
Ø
AstraZeneca
Ø
Johnson & Johnson Services, Inc.
Ø
F. Hoffmann La-Roche Ltd.
Ø
B. Braun Melsungen AG
Ø
Bayer AG
Ø
Becton
Ø
Dickinson and Company
Ø
BoehringerIngelheim International GmbH
Ø
DexCom, Inc.
Ø
Eli Lilly and Company
Ø
Lupin Limited
Ø
Novo Nordisk A/S
Ø
Medtronic, Inc.
Ø
Merck & Co., Inc.
Ø
Novartis AG
Ø Sanofi.
Request TOC: https://www.crystalmarketresearch.com/report/diabetes-devices-and-drugs-market#customization
Diabetes Devices and Drugs Market Segmentation:
By Devices:
- Insulin Delivery Devices
o
Insulin Injectors
o
Insulin Syringes
o
Insulin Pumps
o
Insulin Pens
- Diabetes Monitoring and Diagnostic
Devices
o
Continuous Glucose
Monitoring Devices
o
Analog Glucose Meter
o
Lancets and Lancing
Devices
o
Glucose Test Strips
o
Others
By Therapy:
- Non-insulin Injectable
Anti-diabetes Drugs
o
GLP-1 Analogs
- Oral Anti-diabetes Drugs Class
o
SGLT-2 Inhibitors
o
Sulphonylureas
o
Thiazolidinediones
o
DPP-4 Inhibitors
o
Biguanides
o
Alpha-glucosidaseInhibitors
o
Meglitinides
- Insulin
o
Premixed Insulin
Derivatives
o
Intermediate-acting
Insulin Derivatives
o
Rapid-acting Insulin
Derivatives
o
Short-acting Insulin
Derivatives
o
Long-acting Insulin
Derivatives
By
Region:
- North
America
o
U.S
o
Canada
o
Mexico
- Europe
o
Germany
o
France
o
UK
o
Italy
o
Spain
o
Rest of Europe
- Asia-Pacific
o
Japan
o
China
o
Australia
o
India
o
South Korea
o
Rest of Asia-Pacific
- Rest
of the World
o
Brazil
o
South Africa
o
Saudi Arabia
o
Turkey
o
United Arab Emirates
o
Others
About Us:
Crystal Market Research is a U.S. based
market research and business intelligence company. Crystal offers one stop
solution for market research, business intelligence, and consulting services to
help clients make more informed decisions. It provides both syndicated as well
as customized research studies for its customers spread across the globe. The
company offers market intelligence reports across a broad range of industries
including healthcare, chemicals & materials, technology, automotive, and
energy.
Contact Us:
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Website:
www.crystalmarketresearch.com
Comments
Post a Comment